Skip to main content
Caplight Logo









PhageLab

PhageLab

Private
SantiagoHealthcare & Life Scienceshttp://phagelab.com/

Last Round

VC Round

Apr 10, 2026

Total Funding Raised

$44.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

PhageLab is a biotechnology company that develops tailor-made antibacterial solutions based on bacteriophages for the livestock and poultry industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

bacteriophage technologyphage therapyantibiotic alternativeslivestock healthAI drug discoveryagritechantimicrobial resistanceAMRbacteriophage cocktailsfood safetyprecision animal healthpathogen controlanimal diagnosticspoultry healthcattle healthzootechnical additives

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PhageLab Comparables

Compare PhageLab with similar companies based on industry and business-model similarity.

PhageLab comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Phagos
82%
Proteon Pharmaceuticals
82%
Cytophage Technologies
77%

PhageLab Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 10, 2026
Convertible DebtDec 11, 2025
Series AJan 23, 2024
Series AOct 5, 2021

PhageLab Investors

Notable investors and investment history

PhageLab investors
InvestorRounds
NazcaSeries A
Humboldt FundSeries A
Collaborative FundSeries A
WaterlemonSeries A
The Yield LabConvertible Debt
KaszekSeries A, Convertible Debt, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 10, 2026

    $3M round led by Kaszek.

  • Dec 11, 2025

    $4M round led by Kaszek

PhageLab Filings

Explore SEC and related filing metadata, where available.

PhageLab filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PhageLab's valuation, stock price, and market status.

Is PhageLab a public or private company?

PhageLab is a private company.

What is the current stock price of PhageLab?

PhageLab is a private company with no public stock price. No recent secondary market data is available.

How much is PhageLab worth (valuation)?

Valuation information for PhageLab is not publicly available.

Can I buy PhageLab stock?

PhageLab shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PhageLab's last funding round?

Funding round information for PhageLab is not publicly available.

Who are the main investors in PhageLab?

Investor information for PhageLab is not publicly disclosed.

Will PhageLab IPO soon?

No public IPO plans have been announced for PhageLab.

How can I track PhageLab secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PhageLab's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSantiago
Year Founded2009
Last FundingApr 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?